{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:56Z","timestamp":1790118896221,"version":"4.0.1"},"publisher-location":"Cham","reference-count":74,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030055417","type":"print"},{"value":"9783030055424","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-05542-4_4","type":"book-chapter","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T07:38:30Z","timestamp":1549957110000},"page":"71-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lymphocytes, Platelets, Erythrocytes, and Exosomes as Possible Biomarkers for Alzheimer\u2019s Disease Clinical Diagnosis"],"prefix":"10.1007","author":[{"given":"Ryszard","family":"Pluta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzena","family":"U\u0142amek-Kozio\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1002\/gps.2631","volume":"26","author":"K Engedal","year":"2011","unstructured":"Engedal K, Barca ML, Laks J, Selbaek G (2011) Depression in Alzheimer\u2019s disease: specificity of depressive symptoms using three different clinical criteria. Int J Geriatr Psychiatry 26:944\u2013951","journal-title":"Int J Geriatr Psychiatry"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.22248","volume":"69","author":"VL Villemagne","year":"2011","unstructured":"Villemagne VL, Pike KE, Chetelat G, Ellis KA, Mulligan RS, Bourgeat P et al (2011) Longitudinal assessment of Abeta and cognition in aging and Alzheimer disease. Ann Neurol 69:181\u2013192","journal-title":"Ann Neurol"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O et al (2013) Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367","journal-title":"Lancet Neurol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13825585.2013.795514","volume":"21","author":"NC Rushing","year":"2014","unstructured":"Rushing NC, Sachs-Ericsson N, Steffens DC (2014) Neuropsychological indicators of preclinical Alzheimer\u2019s disease among depressed older adults. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 21:99\u2013128","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","volume":"190","author":"QF Zhao","year":"2016","unstructured":"Zhao QF, Tan L, Wang HF, Jiang T, Tan MS, Tan L et al (2016) The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: systematic review and meta-analysis. J Affect Disord 190:264\u2013271","journal-title":"J Affect Disord"},{"key":"4_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-019082","volume":"8","author":"F Landeiro","year":"2018","unstructured":"Landeiro F, Walsh K, Ghinai I, Mughal S, Nye E, Wace H et al (2018) Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol. BMJ Open 8:e019082. https:\/\/doi.org\/10.1136\/bmjopen-2017-019082","journal-title":"BMJ Open"},{"key":"4_CR7","unstructured":"www.alz.org . 2018"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s11064-007-9302-4","volume":"32","author":"Z Hu","year":"2007","unstructured":"Hu Z, Zeng L, Huang Z, Zhang J, Li T (2007) The study of Golgi apparatus in Alzheimer\u2019s disease. Neurochem Res 32:1265\u20131277","journal-title":"Neurochem Res"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","volume":"15","author":"LE Hebert","year":"2001","unstructured":"Hebert LE, Beckett LA, Scherr PA, Evans DA (2001) Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050. Alzheimer Dis Assoc Disord 15:169\u2013173","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63\u201375.e62. https:\/\/doi.org\/10.1016\/j.jalz.2012.11.007","journal-title":"Alzheimers Dement"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","volume":"15","author":"B Winblad","year":"2016","unstructured":"Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H et al (2016) Defeating Alzheimer\u2019s disease and other dementias: a priority for European science and society. Lancet Neurol 15:455\u2013532","journal-title":"Lancet Neurol"},{"key":"4_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2015.00065","volume":"9","author":"I Canobbio","year":"2015","unstructured":"Canobbio I, Abubaker AA, Visconte C, Torti M, Pula G (2015) Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer\u2019s disease. Front Cell Neurosci 9:65. https:\/\/doi.org\/10.3389\/fncel.2015.00065","journal-title":"Front Cell Neurosci"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12035-012-8360-z","volume":"47","author":"R Pluta","year":"2013","unstructured":"Pluta R, Furmaga-Jab\u0142o\u0144ska W, Maciejewski R, U\u0142amek-Kozio\u0142 M, Jab\u0142o\u0144ski M (2013) Brain ischemia activates \u03b2- and \u03b3-secretase cleavage of amyloid precursor protein: significance in sporadic Alzheimer\u2019s disease. Mol Neurobiol 47:425\u2013434","journal-title":"Mol Neurobiol"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12035-013-8439-1","volume":"48","author":"R Pluta","year":"2013","unstructured":"Pluta R, Jab\u0142o\u0144ski M, U\u0142amek-Kozio\u0142 M, Kocki J, Brzozowska J, Januszewski S et al (2013) Sporadic Alzheimer\u2019s disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer\u2019s disease genes. Mol Neurobiol 48:500\u2013515","journal-title":"Mol Neurobiol"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5114\/fn.2018.74655","volume":"56","author":"R Pluta","year":"2018","unstructured":"Pluta R, U\u0142amek-Kozio\u0142 M, Januszewski S, Czuczwar SJ (2018) Platelets, lymphocytes and erythrocytes from Alzheimer\u2019s disease patients: the quest for blood cell-based biomarkers. Folia Neuropathol 56:14\u201320","journal-title":"Folia Neuropathol"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S et al (2016) Alzheimer\u2019s disease. Lancet 388:505\u2013517","journal-title":"Lancet"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0006-8993(94)91081-2","volume":"649","author":"R Pluta","year":"1994","unstructured":"Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski MJ, Wisniewski HM (1994) Complete cerebral ischemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer\u2019s \u03b2-amyloid protein precursor in the brain. Brain Res 649:323\u2013328","journal-title":"Brain Res"},{"key":"4_CR18","volume-title":"Ischemia-reperfusion pathways in Alzheimer\u2019s disease","author":"R Pluta","year":"2007","unstructured":"Pluta R (2007) Ischemia-reperfusion pathways in Alzheimer\u2019s disease. Nova Science Publisher, Inc., New York ISBN-10:1600217443"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/ar.21018","volume":"292","author":"R Pluta","year":"2009","unstructured":"Pluta R, U\u0142amek M, Jab\u0142o\u0144ski M (2009) Alzheimer\u2019s mechanisms in ischemic brain degeneration. Anat Rec 292:1863\u20131881","journal-title":"Anat Rec"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3233\/JAD-150299","volume":"47","author":"J Kocki","year":"2015","unstructured":"Kocki J, U\u0142amek-Kozio\u0142 M, Bogucka-Kocka A, Januszewski S, Jab\u0142o\u0144ski M, Gil-Kulik P et al (2015) Dysregulation of amyloid precursor protein, \u03b2-secretase, presenilin 1 and 2 genes in the rat selectively vulnerable CA1 subfield of hippocampus following transient global brain ischemia. J Alzheimers Dis 47:1047\u20131056","journal-title":"J Alzheimers Dis"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.pharep.2015.08.002","volume":"68","author":"R Pluta","year":"2016","unstructured":"Pluta R, Kocki J, U\u0142amek-Kozio\u0142 M, Bogucka-Kocka A, Gil-Kulik P, Januszewski S et al (2016) Alzheimer-associated presenilin 2 gene is dysregulated in rat medial temporal lobe cortex after complete brain ischemia due to cardiac arrest. Pharmacol Rep 68:155\u2013161","journal-title":"Pharmacol Rep"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JAD-151102","volume":"51","author":"R Pluta","year":"2016","unstructured":"Pluta R, Kocki J, U\u0142amek-Kozio\u0142 M, Petniak A, Gil-Kulik P, Januszewski S et al (2016) Discrepancy in expression of \u03b2-secretase and amyloid-\u03b2 protein precursor in Alzheimer-related genes in the rat medial temporal lobe cortex following transient global brain ischemia. J Alzheimers Dis 51:1023\u20131031","journal-title":"J Alzheimers Dis"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-160387","volume":"54","author":"M U\u0142amek-Kozio\u0142","year":"2016","unstructured":"U\u0142amek-Kozio\u0142 M, Kocki J, Bogucka-Kocka A, Petniak A, Gil-Kulik P, Januszewski S et al (2016) Dysregulation of autophagy, mitophagy and apoptotic genes in the medial temporal lobe cortex in an ischemic model of Alzheimer\u2019s disease. J Alzheimers Dis 54:113\u2013121","journal-title":"J Alzheimers Dis"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.pharep.2017.07.015","volume":"69","author":"M U\u0142amek-Kozio\u0142","year":"2017","unstructured":"U\u0142amek-Kozio\u0142 M, Kocki J, Bogucka-Kocka A, Januszewski S, Bogucki J, Czuczwar SJ et al (2017) Autophagy, mitophagy and apoptotic gene changes in the hippocampal CA1 area in a rat ischemic model of Alzheimer\u2019s disease. Pharmacol Rep 69:1289\u20131294","journal-title":"Pharmacol Rep"},{"key":"4_CR25","first-page":"881","volume":"70","author":"R Pluta","year":"2018","unstructured":"Pluta R, Bogucka-Kocka A, U\u0142amek-Kozio\u0142 M, Bogucki J, Januszewski S, Kocki J et\u00a0al (2018) Ischemic tau protein gene induction as an additional key factor driving development of Alzheimer\u2019s phenotype changes in CA1 area of hippocampus in an ischemic model of Alzheimer\u2019s disease. Pharmacol\u00a070:881\u2013884","journal-title":"Pharmacol"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1177\/2211068214559979","volume":"20","author":"C Schaffer","year":"2015","unstructured":"Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J et\u00a0al (2015) Biomarkers in the diagnosis and prognosis of Alzheimer\u2019s disease. J Lab Autom 20:589\u2013600","journal-title":"J Lab Autom"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement 7:263\u2013269","journal-title":"Alzheimers Dement"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2014","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB et al (2014) Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement 11:600\u2013607","journal-title":"Alzheimers Dement"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3233\/JAD-141725","volume":"44","author":"JL Seeburger","year":"2015","unstructured":"Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M et al (2015) Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer\u2019s disease from other dementias and healthy controls in the optima cohort. J Alzheimers Dis 44:525\u2013539","journal-title":"J Alzheimers Dis"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/978-1-4939-2627-5_32","volume":"1303","author":"R Perneczky","year":"2016","unstructured":"Perneczky R, Guo LH (2016) Plasma proteomics biomarkers in Alzheimer\u2019s disease: latest advances and challenges. Methods Mol Biol 1303:521\u2013529","journal-title":"Methods Mol Biol"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4626540","volume":"2017","author":"Anna Mietelska-Porowska","year":"2017","unstructured":"Mietelska-Porowska A, Wojda U (2017) T lymphocytes and inflammatory mediators in the interplay between brain and blood in Alzheimer\u2019s disease: potential pools of new biomarkers. J Immunol Res 17. https:\/\/doi.org\/10.1155\/2017\/4626540","journal-title":"Journal of Immunology Research"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.3233\/JAD-170363","volume":"60","author":"A Stevenson","year":"2017","unstructured":"Stevenson A, Lopez D, Khoo P, Kalaria RN, Mukaetova-Ladinska EB (2017) Exploring erythrocytes as blood biomarkers for Alzheimer\u2019s disease. J Alzheimers Dis 60:845\u2013857","journal-title":"J Alzheimers Dis"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2217\/bmm-2017-0041","volume":"11","author":"J Wojsiat","year":"2017","unstructured":"Wojsiat J, Laskowska-Kaszub K, Mietelska-Porowska A, Wojda U (2017) Search for Alzheimer\u2019s disease biomarkers in blood cells: hypotheses-driven approach. Biomark Med 11:917\u2013931","journal-title":"Biomark Med"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms17020173","volume":"17","author":"LJ Vella","year":"2016","unstructured":"Vella LJ, Hill AF, Cheng L (2016) Focus on extracellular vesicles: exosomes and their role in protein trafficking and biomarker potential in Alzheimer\u2019s and Parkinson\u2019s disease. Int J Mol Sci 17:173. https:\/\/doi.org\/10.3390\/ijms17020173","journal-title":"Int J Mol Sci"},{"key":"4_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00229","volume":"11","author":"K Yuyama","year":"2017","unstructured":"Yuyama K, Igarashi Y (2017) Exosomes as carriers of Alzheimer\u2019s amyloid-\u03b2. Front Neurosci 11:229. https:\/\/doi.org\/10.3389\/fnins.2017.00229","journal-title":"Front Neurosci"},{"key":"4_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-2-65","volume":"2","author":"M Veitinger","year":"2014","unstructured":"Veitinger M, Varga B, Guterres SB, Zellner M (2014) Platelets, a reliable source for peripheral Alzheimer\u2019s disease biomarkers? Acta Neuropathol Commun 2:65. https:\/\/doi.org\/10.1186\/2051-5960-2-65","journal-title":"Acta Neuropathol Commun"},{"key":"4_CR38","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1447-0594.2012.00866.x","volume":"13","author":"H Sakurai","year":"2013","unstructured":"Sakurai H, Hanyu H, Sato T, Kume K, Hirao K, Kanetaka H et al (2013) Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer\u2019s disease and cerebrovascular disease: a pilot study. Geriatr Gerontol Int 13:90\u201397","journal-title":"Geriatr Gerontol Int"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/09537100500181913","volume":"17","author":"CI Prodan","year":"2006","unstructured":"Prodan CI, Szasz R, Vincent AS, Ross ED, Dale GL (2006) Coated platelets retain amyloid precursor protein on their surface. Platelets 17:56\u201360","journal-title":"Platelets"},{"key":"4_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.trsl.2008.07.001","volume":"152","author":"CI Prodan","year":"2008","unstructured":"Prodan CI, Ross ED, Vincent AS, Dale GL (2008) Rate of progression in Alzheimer\u2019s disease correlates with coated-platelet levels\u2013a longitudinal study. Transl Res 152:99\u2013102","journal-title":"Transl Res"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/JAD-2011-101641","volume":"25","author":"K Neumann","year":"2011","unstructured":"Neumann K, Farias G, Slachevsky A, Perez P, Maccioni RB (2011) Human platelet tau: a potential peripheral marker for Alzheimer\u2019s disease. J Alzheimers Dis 25:103\u2013109","journal-title":"J Alzheimers Dis"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3233\/JAD-2012-120304","volume":"31","author":"G Farias","year":"2012","unstructured":"Farias G, Perez P, Slachevsky A, Maccioni RB (2012) Platelet tau pattern correlates with cognitive status in Alzheimer\u2019s disease. J Alzheimers Dis 31:65\u201369","journal-title":"J Alzheimers Dis"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.3233\/JAD-160652","volume":"55","author":"A Slachevsky","year":"2017","unstructured":"Slachevsky A, Guzman-Mart\u0131nez L, Delgado C, Reyes P, Far\u0131as GA, Munoz-Neira C et al (2017) Tau platelets correlate with regional brain atrophy in patients with Alzheimer\u2019s disease. J Alzheimers Dis 55:1595\u20131603","journal-title":"J Alzheimers Dis"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.bbadis.2015.03.015","volume":"1852","author":"SI Mota","year":"2015","unstructured":"Mota SI, Costa RO, Ferreira IL, Santana I, Caldeira GL, Padovano C et al (2015) Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer\u2019s disease. Biochim Biophys Acta 1852:1428\u20131441","journal-title":"Biochim Biophys Acta"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3233\/JAD-141977","volume":"46","author":"J Wojsiat","year":"2015","unstructured":"Wojsiat J, Prandelli C, Laskowska-Kaszub K, Mart\u00edn Requero A, Wojda U (2015) Oxidative stress and aberrant cell cycle in Alzheimer\u2019s disease lymphocytes: diagnostic prospects. J Alzheimers Dis 46:329\u2013350","journal-title":"J Alzheimers Dis"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2217\/bmm.15.79","volume":"10","author":"U Wojda","year":"2016","unstructured":"Wojda U (2016) Alzheimer\u2019s disease lymphocytes: potential for biomarkers. Biomark Med 10:1\u20134","journal-title":"Biomark Med"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.neurobiolaging.2014.09.025","volume":"36","author":"A Kuhla","year":"2015","unstructured":"Kuhla A, Ludwig SC, Kuhla B, M\u00fcnch G, Vollmar B (2015) Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer\u2019s disease brain. Neurobiol Aging 36:753\u2013761","journal-title":"Neurobiol Aging"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00146965-200309000-00004","volume":"16","author":"J Zhang","year":"2003","unstructured":"Zhang J, Kong Q, Zhang Z, Ge P, Ba D, He W (2003) Telomere dysfunction of lymphocytes in patients with Alzheimer disease. Cogn Behav Neurol 16:170\u2013176","journal-title":"Cogn Behav Neurol"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jpsychires.2006.01.010","volume":"41","author":"E Richartz-Salzburger","year":"2007","unstructured":"Richartz-Salzburger E, Batra A, Stransky E, Laske C, K\u00f6hler N, Bartels M et al (2007) Altered lymphocyte distribution in Alzheimer\u2019s disease. J Psychiatr Res 41:174\u2013178","journal-title":"J Psychiatr Res"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.neubiorev.2016.06.014","volume":"68","author":"SA Mesquita Da","year":"2016","unstructured":"Da Mesquita SA, Ferreira C, Sousa JC, Correia-Neves M, Sousa N, Marques F (2016) Insights on the pathophysiology of Alzheimer\u2019s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev 68:547\u2013562","journal-title":"Neurosci Biobehav Rev"},{"key":"4_CR51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.18632\/oncoscience.309","volume":"3","author":"F Licastro","year":"2016","unstructured":"Licastro F, Porcellini E (2016) Persistent infections, immune-senescence and Alzheimer\u2019s disease. Oncoscience 3:135\u2013142","journal-title":"Oncoscience"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.it.2016.08.001","volume":"37","author":"M Schwartz","year":"2016","unstructured":"Schwartz M, Deczkowska A (2016) Neurological disease as a failure of brain-immune crosstalk: the multiple faces of neuroinflammation. Trends Immunol 37:668\u2013679","journal-title":"Trends Immunol"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14737175.2016.1200972","volume":"17","author":"WJ Deardorff","year":"2017","unstructured":"Deardorff WJ, Grossberg GT (2017) Targeting neuroinflammation in Alzheimer\u2019s disease: evidence for NSAIDs and novel therapeutics. Expert Rev Neurother 17:17\u201332","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"4_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049620","volume":"7","author":"T Kiko","year":"2012","unstructured":"Kiko T, Nakagawa K, Satoh A, Tsuduki T, Furukawa K, Arai H et al (2012) Amyloid beta levels in human red blood cells. PLoS One 7(11):e49620. https:\/\/doi.org\/10.1371\/journal.pone.0049620","journal-title":"PLoS One"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1271\/bbb.110318","volume":"75","author":"K Nakagawa","year":"2011","unstructured":"Nakagawa K, Kiko T, Kuriwada S, Miyazawa T, Kimura F, Miyazawa T (2011) Amyloid \u03b2 induces adhesion of erythrocytes to endothelial cells and affects endothelial viability and functionality. Biosci Biotechnol Biochem 75:2030\u20132033","journal-title":"Biosci Biotechnol Biochem"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.febslet.2011.03.060","volume":"585","author":"K Nakagawa","year":"2011","unstructured":"Nakagawa K, Kiko T, Miyazawa T, Sookwong P, Tsuduki T, Satoh A et al (2011) Amyloid \u03b2-induced erythrocytic damage and its attenuation by carotenoids. FEBS Lett 585:1249\u20131254","journal-title":"FEBS Lett"},{"issue":"1","key":"4_CR57","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1479-5876-10-5","volume":"10","author":"Jonathan M Street","year":"2012","unstructured":"Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, Walsh TS et al (2012) Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 10. https:\/\/doi.org\/10.1186\/1479-5876-10-5","journal-title":"Journal of Translational Medicine"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/ki.2013.502","volume":"86","author":"L Cheng","year":"2013","unstructured":"Cheng L, Sun X, Scicluna BJ, Coleman BM, Hill AF (2013) Characterization and deep sequencing analysis of exosomal and non-exosomal miRNA in human urine. Kidney Int 86:433\u2013444","journal-title":"Kidney Int"},{"issue":"1","key":"4_CR59","doi-asserted-by":"publisher","first-page":"23743","DOI":"10.3402\/jev.v3.23743","volume":"3","author":"Lesley Cheng","year":"2014","unstructured":"Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3.\u00a0 https:\/\/doi.org\/10.3402\/jev.v3.23743","journal-title":"Journal of Extracellular Vesicles"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3390\/ijms17020170","volume":"17","author":"H Kalra","year":"2016","unstructured":"Kalra H, Drummen GPC, Mathivanan S (2016) Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci 17:170. https:\/\/doi.org\/10.3390\/ijms17020170","journal-title":"Int J Mol Sci"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jprot.2014.04.028","volume":"106","author":"D Chiasserini","year":"2014","unstructured":"Chiasserini D, van Weering JR, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE et al (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteome 106:191\u2013204","journal-title":"J Proteome"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S et al (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287:3842\u20133849","journal-title":"J Biol Chem"},{"key":"4_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00125","volume":"6","author":"I Lopez-Font","year":"2015","unstructured":"Lopez-Font I, Cuchillo-Ibanez I, Sogorb-Esteve A, Garcia-Ayllon MS, Saez-Valero J (2015) Transmembrane amyloid-related proteins in CSF as potential biomarkers for Alzheimer\u2019s disease. Front Neurol 6:125. https:\/\/doi.org\/10.3389\/fneur.2015.00125","journal-title":"Front Neurol"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/mp.2014.127","volume":"20","author":"L Cheng","year":"2014","unstructured":"Cheng L, Doecke JD, Sharples RA, Villemagne VL, Fowler CJ, Rembach A et al (2014) Prognostic serum miRNA biomarkers associated with Alzheimer\u2019s disease shows concordance with neuropsychological and neuroimaging assessment. Mol Psychiatry 20:1188\u20131196","journal-title":"Mol Psychiatry"},{"key":"4_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00229","volume":"3","author":"V Vingtdeux","year":"2012","unstructured":"Vingtdeux V, Sergeant N, Buee L (2012) Potential contribution of exosomes to the prion-like propagation of lesions in Alzheimer\u2019s disease. Front Physiol 3:229. https:\/\/doi.org\/10.3389\/fphys.2012.00229","journal-title":"Front Physiol"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00401-011-0912-1","volume":"123","author":"T Hamaguchi","year":"2012","unstructured":"Hamaguchi T, Eisele YS, Varvel NH, Lamb BT, Walker LC, Jucker M (2012) The presence of A\u03b2 seeds, and not age per se, is critical to the initiation of A\u03b2 deposition in the brain. Acta Neuropathol 123:31\u201337","journal-title":"Acta Neuropathol"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1523\/JNEUROSCI.0615-12.2012","volume":"32","author":"S Nath","year":"2012","unstructured":"Nath S, Agholme L, Kurudenkandy FR, Granseth B, Marcusson J, Hallbeck M (2012) Spreading of neurodegenerative pathology via neuron-to-neuron transmission of \u03b2-amyloid. J Neurosci 32:8767\u20138777","journal-title":"J Neurosci"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nbd.2013.12.019","volume":"65","author":"J Domert","year":"2014","unstructured":"Domert J, Rao SB, Agholme L, Brorsson AC, Marcusson J, Hallbeck M et al (2014) Spreading of amyloid-\u03b2 peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance. Neurobiol Dis 65:82\u201392","journal-title":"Neurobiol Dis"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1901","volume":"11","author":"F Clavaguera","year":"2009","unstructured":"Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A et al (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11:909\u2013913","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4_CR70","doi-asserted-by":"publisher","first-page":"e31302","DOI":"10.1371\/journal.pone.0031302","volume":"7","author":"Li Liu","year":"2012","unstructured":"Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C et al (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7:e31302.\u00a0doi: 10.1371\/journal.pone.0031302","journal-title":"PLoS ONE"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"TM Heneka","year":"2015","unstructured":"Heneka TM, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL et al (2015) Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol 14:388\u2013405","journal-title":"Lancet Neurol"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3233\/JAD-170953","volume":"62","author":"R Ghidoni","year":"2018","unstructured":"Ghidoni R, Squitti R, Siotto M, Benussi L (2018) Innovative biomarkers for Alzheimer\u2019s disease: focus on the hidden disease biomarkers. J Alzheimers Dis 62:1507\u20131518","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"4_CR73","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-018-0514-4","volume":"6","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Durisic N, Sullivan R, G\u00f6tz J (2018) Exosomes taken up by neurons hijack the endosomal pathway to spread to interconnected neurons. Acta Neuropathol Commun 6(1):10. https:\/\/doi.org\/10.1186\/s40478-018-0514-4","journal-title":"Acta Neuropathol Commun"},{"key":"4_CR74","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuint.2017.12.009","volume":"114","author":"T Zheng","year":"2018","unstructured":"Zheng T, Wu X, Wei X, Wang M, Zhang B (2018) The release and transmission of amyloid precursor protein via exosomes. Neurochem Int 114:18\u2013253","journal-title":"Neurochem Int"}],"container-title":["Advances in Experimental Medicine and Biology","Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-05542-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T12:30:11Z","timestamp":1606480211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-05542-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030055417","9783030055424"],"references-count":74,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-05542-4_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"13 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}